News | RIVM

Menthol facilitates inhalation of tobacco smoke, even when you cannot taste it

Even when menthol cannot be tasted, the substance makes it easier to inhale tobacco smoke. This way, menthol makes smoking more attractive for young and novice smokers who are not yet used to inhaling sharp, pungent tobacco smoke.

Exploratory study on continuation of COVID-19 Vaccination Programme

RIVM has commissioned ABDTOPconsult to do an independent exploratory study on systematic approaches to organising and incorporating the current RIVM COVID-19 Vaccination Programme.

Early indicators added to coronavirus monitoring in sewage on Coronavirus Dashboard

This week, early indicators were added to the sewage measurements page on the Coronavirus Dashboard provided by the national government. These values help to clarify the measurements by indicating how serious the situation is.

Signaalwaarden geven de rioolwatermetingen meer duiding

Delta variant on the rise

The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.

COVID-19 vaccination very effective: major drop in positive tests, hospital admissions and deaths among older people

People over 75 years old living at home are 82% protected against testing positive for COVID-19 from three weeks after the second vaccination.

Dame ontvangt een vaccinatie tegen COVID-19

Launch of the European project RISK-HUNT3R

The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.

Effects of COVID-19 vaccination becoming increasingly visible

In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.

At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences

Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.

Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands

In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.

Long-term symptoms more common after Lyme disease

More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.